David Saxon
Stock Analyst at Needham
(1.09)
# 3,682
Out of 4,468 analysts
488
Total ratings
35%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by David Saxon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CARL Carlsmed | Initiated Coverage: Buy | $17 | $11.34 | +49.91% | 1 | Jul 1, 2026 | |
| GKOS Glaukos | Maintained: Buy | $136 → $150 | $148.34 | +1.12% | 27 | Jun 17, 2026 | |
| COO The Cooper Companies | Rated: Buy | $101 → $86 | $74.20 | +15.90% | 27 | Jun 5, 2026 | |
| SIBN SI-BONE | Reiterated: Buy | $27 | $17.11 | +57.80% | 49 | Jun 3, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | n/a | $27.79 | - | 36 | May 14, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $114 → $117 | $80.12 | +46.03% | 28 | May 8, 2026 | |
| NVST Envista Holdings | Maintained: Hold | $27 | $27.63 | -2.28% | 17 | May 7, 2026 | |
| SGHT Sight Sciences | Maintained: Hold | n/a | $5.45 | - | 23 | May 7, 2026 | |
| RXST RxSight | Reiterated: Buy | $13 → $11 | $5.61 | +96.08% | 38 | May 7, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $25 → $14 | $8.92 | +56.95% | 39 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $33 | $25.84 | +27.71% | 40 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.65 | - | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 80.31 → CHF 76.29 | $55.04 | +38.61% | 37 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $15 | $15.49 | -3.16% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $254 → $255 | $126.52 | +101.55% | 41 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $184 | $184.52 | -0.28% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.16 | - | 17 | Apr 29, 2026 |
Carlsmed
Jul 1, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $11.34
Upside: +49.91%
Glaukos
Jun 17, 2026
Maintained: Buy
Price Target: $136 → $150
Current: $148.34
Upside: +1.12%
The Cooper Companies
Jun 5, 2026
Rated: Buy
Price Target: $101 → $86
Current: $74.20
Upside: +15.90%
SI-BONE
Jun 3, 2026
Reiterated: Buy
Price Target: $27
Current: $17.11
Upside: +57.80%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $27.79
Upside: -
Globus Medical
May 8, 2026
Reiterated: Buy
Price Target: $114 → $117
Current: $80.12
Upside: +46.03%
Envista Holdings
May 7, 2026
Maintained: Hold
Price Target: $27
Current: $27.63
Upside: -2.28%
Sight Sciences
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $5.45
Upside: -
RxSight
May 7, 2026
Reiterated: Buy
Price Target: $13 → $11
Current: $5.61
Upside: +96.08%
Alphatec Holdings
May 6, 2026
Reiterated: Buy
Price Target: $25 → $14
Current: $8.92
Upside: +56.95%
May 6, 2026
Reiterated: Buy
Price Target: $44 → $33
Current: $25.84
Upside: +27.71%
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $11.65
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: CHF 80.31 → CHF 76.29
Current: $55.04
Upside: +38.61%
May 5, 2026
Rated: Buy
Price Target: $13 → $15
Current: $15.49
Upside: -3.16%
May 1, 2026
Reiterated: Buy
Price Target: $254 → $255
Current: $126.52
Upside: +101.55%
Apr 30, 2026
Maintained: Hold
Price Target: $184
Current: $184.52
Upside: -0.28%
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $17.16
Upside: -